Reports

Global Cancer/Tumour Profiling Market Size, Forecast: By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others; By Biomarker Type: Genetic Biomarkers, Protein Biomarkers; By Technology: Immunoassays, Others; By Application; Regional Analysis; Competitive Landscape; 2024-2032

Global Cancer/Tumour Profiling Market Outlook

The global cancer/tumour profiling market attained a value of USD around 10.44 billion in 2023. The cancer/tumour profiling market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 10.2% to reach USD 25.07 billion by 2032.

Global Cancer/Tumour Profiling Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The rising rate of cancer globally and the growing use of biomarkers in the production of tumours are the main drivers for the growth of the cancer/tumour profiling market.

Market Segmentation

Cancer is a life-threatening illness that is characterised by uncontrolled cell growth. This is mainly due to environmental reasons which alter the gene encoding that regulates cells. The resulting cell mutation results in abnormal cell growth, killing the surrounding normal tissue and then spreading it to very important organs. Cancer/tumour profiling is done to gain insight into a patient's cancer profile and genomic adjustments that enable physicians to guide a patient to the most appropriate treatment. Therefore, profiling also allows doctors to avoid interventions that are questionable and, thus, reduce mistakes and trial procedures.

Global Cancer/Tumour Profiling Market By Technology

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The types of cancer can be divided into:

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Others

The types of biosensors can be segmented into:

Genetic Biomarkers
Protein Biomarkers
Others

The cancer/tumour profiling market can be broadly categorised based on technology into:

Immunoassays
Next-Generation Sequencing
Polymerase Chain Reaction
In Situ Hybridization
Microarrays
Mass Spectrometry
Others

It finds its uses in the research and clinical applications.

Research applications can be further divided into:

Biomarker Discovery
Personalized Medicine

Clinical applications are further categorised into:

Diagnostics
Prognostics
Monitoring and Treatment
Screening

The EMR report looks into the regional markets of cancer/tumour profiling like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Global Cancer/Tumour Profiling Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

A significant growth in the global market for cancer/tumour profiling is expected in the coming years, mainly owing to the increased funding of activities to improve the overall course of the diagnosis and treatment of the disease and the recent comprehensive technological advancements in the area of tumour profiling. The market is also being driven by the growing use of medical diagnostics and the resulting increase in the demand for personalized medicinal products.

The constantly increasing socio-economic burden of cancer and the demand from the health industry to establish effective methods of treating and controlling it also drives the market for the profiling of cancer/tumours. Nonetheless, the additional expenditure needed by profiling procedures may in some way impede its adoption, limiting the scope of these processes to high-income regions. Nonetheless, through government intervention and support from the public and private institutions for cancer diagnosis and treatment are expected to allow the market to achieve promising avenues for development.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global cancer/tumour profiling market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

Illumina, Inc. (NASDAQ: ILMN)
Qiagen N.V.
Neogenomic Laboratories, Inc.
Sysmex Corporation
HTG Molecular Diagnostics, Inc.
Helomics Corporation
Caris Life Sciences
Others

The EMR report gives an in-depth insight into the cancer/tumour profiling market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

REPORT FEATURES	DETAILS
Base Year	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Scope of the Report	Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Cancer Type, Biomarker Type, Technology, Application, Region
Breakup by Cancer Type	Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others
Breakup by Biomarker Type	Genetic Biomarkers, Protein Biomarkers, Others
Breakup by Technology	Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, Mass Spectrometry, Others
Breakup by Application	Research Applications, Clinical Applications
Breakup by Region	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics	SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape	Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered	Illumina, Inc. (NASDAQ: ILMN), Qiagen N.V. (NYSE: QGEN), Neogenomic Laboratories, Inc. (NASDAQ: NEO), Sysmex Corporation (TYO: 6869), HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM), Helomics Corporation, Caris Life Sciences, Others
Report Price and Purchase Option	Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format	Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1   Preface
2   Report Coverage – Key Segmentation and Scope
3   Report Description
   3.1   Market Definition and Outlook
   3.2   Properties and Applications
   3.3   Market Analysis
   3.4   Key Players
4   Key Assumptions
5   Executive Summary
   5.1   Overview
   5.2   Key Drivers
   5.3   Key Developments
   5.4   Competitive Structure
   5.5   Key Industrial Trends
6   Snapshot
   6.1   Global
   6.2   Regional
7   Opportunities and Challenges in the Market
8   Global Cancer/Tumour Profiling Market Analysis
   8.1   Key Industry Highlights
   8.2   Global Cancer/Tumour Profiling Historical Market (2018-2023)
   8.3   Global Cancer/Tumour Profiling Market Forecast (2024-2032)
   8.4   Global Cancer/Tumour Profiling Market by Cancer Type
       8.4.1   Breast Cancer
8.4.1.1 Historical Trend (2018-2023)
           8.4.1.2 Forecast Trend (2024-2032)
       8.4.2   Lung Cancer
8.4.2.1 Historical Trend (2018-2023)
           8.4.2.2 Forecast Trend (2024-2032)
       8.4.3   Colorectal Cancer
8.4.3.1 Historical Trend (2018-2023)
           8.4.3.2 Forecast Trend (2024-2032)
       8.4.4   Prostate Cancer
8.4.4.1 Historical Trend (2018-2023)
           8.4.4.2 Forecast Trend (2024-2032)
       8.4.5   Melanoma
8.4.5.1 Historical Trend (2018-2023)
           8.4.5.2 Forecast Trend (2024-2032)
       8.4.6   Others
   8.5   Global Cancer/Tumour Profiling Market by Biomarker Type
       8.5.1   Genetic Biomarkers
8.5.1.1 Historical Trend (2018-2023)
           8.5.1.2 Forecast Trend (2024-2032)
       8.5.2   Protein Biomarkers
8.5.2.1 Historical Trend (2018-2023)
           8.5.2.2 Forecast Trend (2024-2032)
       8.5.3   Others
   8.6   Global Cancer/Tumour Profiling Market by Technology
       8.6.1   Immunoassays
8.6.1.1 Historical Trend (2018-2023)
           8.6.1.2 Forecast Trend (2024-2032)
       8.6.2   Next-Generation Sequencing
8.6.2.1 Historical Trend (2018-2023)
           8.6.2.2 Forecast Trend (2024-2032)
       8.6.3   Polymerase Chain Reaction
8.6.3.1 Historical Trend (2018-2023)
           8.6.3.2 Forecast Trend (2024-2032)
       8.6.4   In Situ Hybridization
8.6.4.1 Historical Trend (2018-2023)
           8.6.4.2 Forecast Trend (2024-2032)
       8.6.5   Microarrays
8.6.5.1 Historical Trend (2018-2023)
           8.6.5.2 Forecast Trend (2024-2032)
       8.6.6   Mass Spectrometry
8.6.6.1 Historical Trend (2018-2023)
           8.6.6.2 Forecast Trend (2024-2032)
       8.6.7   Others
   8.7   Global Cancer/Tumour Profiling Market by Application
       8.7.1   Research Applications
8.7.1.1 Historical Trend (2018-2023)
           8.7.1.2 Forecast Trend (2024-2032)
           8.7.1.3 Breakup by Type
               8.7.1.3.1   Biomarker Discovery
               8.7.1.3.2   Personalised Medicine
       8.7.2   Clinical Applications
8.7.2.1 Historical Trend (2018-2023)
           8.7.2.2 Forecast Trend (2024-2032)
           8.7.2.3 Breakup by Type
               8.7.2.3.1   Diagnostics
               8.7.2.3.2   Prognostics
               8.7.2.3.3   Monitoring and Treatment
               8.7.2.3.4   Screening
   8.8 Global Cancer/Tumour Profiling Market by Region
        8.8.1    North America
            8.8.1.1    Historical Trend (2018-2023)
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Europe
            8.8.2.1    Historical Trend (2018-2023)
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Asia Pacific
            8.8.3.1    Historical Trend (2018-2023)
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Latin America
            8.8.4.1    Historical Trend (2018-2023)
            8.8.4.2    Forecast Trend (2024-2032)
        8.8.5    Middle East and Africa
            8.8.5.1    Historical Trend (2018-2023)
            8.8.5.2    Forecast Trend (2024-2032)
9    North America Cancer/Tumour Profiling Market Analysis
    9.1    United States of America
        9.1.1    Historical Trend (2018-2023)
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023)
        9.2.2    Forecast Trend (2024-2032)
10    Europe Cancer/Tumour Profiling Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Cancer/Tumour Profiling Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.2    Historical Trend (2018-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Cancer/Tumour Profiling Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Cancer/Tumour Profiling Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape
    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Illumina, Inc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Qiagen N.V.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    NeoGenomics Laboratories, Inc.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Sysmex Corporation
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    HTG Molecular Diagnostics, Inc.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Helomics Corporation
            16.2.6.1    Company Overview
            16.2.6.2    Product Portfolio
            16.2.6.3    Demographic Reach and Achievements
            16.2.6.4    Certifications
        16.2.7    Caris Life Sciences
            16.2.7.1    Company Overview
            16.2.7.2    Product Portfolio
            16.2.7.3    Demographic Reach and Achievements
            16.2.7.4    Certifications
        16.2.8    Others
17    Key Trends and Developments in the Market

List of Key Figures and Tables

1.   Global Cancer/Tumour Profiling Market: Key Industry Highlights, 2018 and 2032
2.   Global Cancer/Tumour Profiling Historical Market: Breakup by Cancer Type (USD Billion), 2018-2023
3.   Global Cancer/Tumour Profiling Market Forecast: Breakup by Cancer Type (USD Billion), 2024-2032
4.   Global Cancer/Tumour Profiling Historical Market: Breakup by Biomarker Type (USD Billion), 2018-2023
5.   Global Cancer/Tumour Profiling Market Forecast: Breakup by Biomarker Type (USD Billion), 2024-2032
6.   Global Cancer/Tumour Profiling Historical Market: Breakup by Technology (USD Billion), 2018-2023
7.   Global Cancer/Tumour Profiling Market Forecast: Breakup by Technology (USD Billion), 2024-2032
8.   Global Cancer/Tumour Profiling Historical Market: Breakup by Application (USD Billion), 2018-2023
9.   Global Cancer/Tumour Profiling Market Forecast: Breakup by Application (USD Billion), 2024-2032
10.   Global Cancer/Tumour Profiling Historical Market: Breakup by Region (USD Billion), 2018-2023
11.   Global Cancer/Tumour Profiling Market Forecast: Breakup by Region (USD Billion), 2024-2032
12.   North America Cancer/Tumour Profiling Historical Market: Breakup by Country (USD Billion), 2018-2023
13.   North America Cancer/Tumour Profiling Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.   Europe Cancer/Tumour Profiling Historical Market: Breakup by Country (USD Billion), 2018-2023
15.   Europe Cancer/Tumour Profiling Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.   Asia Pacific Cancer/Tumour Profiling Historical Market: Breakup by Country (USD Billion), 2018-2023
17.   Asia Pacific Cancer/Tumour Profiling Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.   Latin America Cancer/Tumour Profiling Historical Market: Breakup by Country (USD Billion), 2018-2023
19.   Latin America Cancer/Tumour Profiling Market Forecast: Breakup by Country (USD Billion), 2024-2032
20.   Middle East and Africa Cancer/Tumour Profiling Historical Market: Breakup by Country (USD Billion), 2018-2023
21.   Middle East and Africa Cancer/Tumour Profiling Market Forecast: Breakup by Country (USD Billion), 2024-2032
22.   Global Cancer/Tumour Profiling Market Structure

Key Questions Answered in the Report

What was the global cancer/tumour profiling market size in 2023?

In 2023, the global cancer/tumour profiling market attained a value of nearly USD 10.44 billion.

What is the growth rate of the market?

The market is projected to grow at a CAGR of 10.2% between 2024 and 2032.

What are the major industry drivers?

The industry is being driven by the rising global incidences of cancer and the expanding usage of biomarkers in identifying the formation of tumours.

What are the key industry trends of the global cancer/tumour profiling market?

The key trends augmenting the market expansion in the forecast period are the increasing funding for activities aimed at improving the overall course of disease diagnosis and treatment, technological advancements in tumour profiling, and the increasing demand for individualised pharmaceutical products.

What are the major regional markets of cancer/tumour profiling, according to the EMR report?

The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

What are the various cancer types in the industry?

The various cancer types in the industry are breast cancer, lung cancer, colorectal cancer, prostate cancer, and melanoma, among others.

What are the major biomarker types of cancer/tumour profiling in the industry?

The major biomarker types of cancer/tumour profiling are genetic biomarkers and protein biomarkers, among others.

What are the significant technologies of cancer/tumour profiling in the market?

The significant technologies of cancer/tumour profiling in the market are immunoassays, next-generation sequencing, polymerase chain reaction, in situ hybridisation, microarrays, and mass spectrometry, among others.

What are the several applications of cancer/tumour profiling?

The several applications of cancer/tumour profiling in the market are research applications and clinical applications.

Who are the key industry players, according to the report?

The major players in the industry are Illumina, Inc., Qiagen N.V., NeoGenomics Laboratories, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Helomics Corporation, and Caris Life Sciences, among others.

Analyst Review

The global cancer/tumour profiling market attained a value of about USD 10.44 billion in 2023, driven by the rising global incidences of cancer. Aided by technological advancements in tumour profiling, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 10.2%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its cancer types, the cancer/tumour profiling industry can be segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, and melanoma, among others. By biomarker types, the industry can be divided into genetic biomarkers and protein biomarkers, among others. On the basis of technology, the market is classified into immunoassays, next-generation sequencing, polymerase chain reaction, in situ hybridisation, microarrays, and mass spectrometry, among others. Based on application, the industry is bifurcated into research activities and clinical applications. The major regional markets for cancer/tumour profiling are North America, Latin America, Europe, the Middle East and Africa, the Asia Pacific. The key players in the above market include Illumina, Inc., Qiagen N.V., NeoGenomics Laboratories, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Helomics Corporation, and Caris Life Sciences, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Request Sample

Purchase Full Report

Mini Report

$1699

Selected Sections, One User
Printing Not Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Single User License

$2799

All Sections, One User
One Print Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Five User License

$3999

All Sections, Five Users
Five Prints Allowed
Email Delivery in PDF
Free Limited Customisation
Post Sales Analyst Support
~~50% Discount on Next Update~~

Buy Now

Corporate License

$4999

All Sections, Unlimited Users
Unlimited Prints Allowed
Email Delivery in PDF + Excel
Free Limited Customisation
Post Sales Analyst Support
50% Discount on Next Update

Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER